Home/Filings/4/0001209191-22-037645
4//SEC Filing

Lettmann Jason 4

Accession 0001209191-22-037645

CIK 0001810182other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 8:26 PM ET

Size

5.4 KB

Accession

0001209191-22-037645

Insider Transaction Report

Form 4
Period: 2022-06-15
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Common Stock (right to buy)

    2022-06-15+12,00412,004 total
    Exercise: $6.67Exp: 2032-06-14Common Stock (12,004 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 12 equal monthly installments on the same day of the month as the grant date, or if earlier, the day immediately before the day of the next annual meeting of stockholders.

Issuer

ALX ONCOLOGY HOLDINGS INC

CIK 0001810182

Entity typeother

Related Parties

1
  • filerCIK 0001688269

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:26 PM ET
Size
5.4 KB